EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Structural basis for recognition of Rift Valley fever virus Gn protein by a human neutralizing monoclonal antibody with a kappa light chain

Guido C Paesen, Nathaniel S Chapman, Jonna B Westover, Cynthia M McMillen, Natalia A Kuzmina, Emmett A Dews, Luke Myers, Robert Stass, Joel M Montgomery, Alexander Bukreyev, Amy L Hartman, Brian B Gowen und 2 weitere

PLOS Pathogens · 2026

DOI: 10.1371/journal.ppat.1013926 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS Pathogens, 2026. Verfasst von Guido C Paesen und 13 weiteren Autor:innen. Beteiligte Einrichtung: Division of Structural Biology, Centre for Human Genetics, University of Oxford, Oxford, United Kingdom. Hauptthemen laut MEDLINE: Rift Valley fever virus, Antibodies, Neutralizing, Antibodies, Monoclonal, Antibodies, Viral. Die Arbeit nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, Medical Research Council, NIH.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Rift Valley fever virus (RVFV) poses a continued threat to human health and animal husbandry. Two neutralizing and protective human monoclonal antibodies (mAbs), RVFV-268 and RVFV-379, exhibit similar affinities and epitope footprints on the Gn glycoprotein component of the RVFV Gn-Gc capsomeric lattice. Here, we define fine details of the biophysical determinants of Gn recognition used by RVFV human monoclonal antibodies through studying an antibody encoded by a set of recombined genes not previously identified in RVFV antibodies. We find that RVFV-379 exhibits a larger footprint than that observed for RVFV-268 and other antibodies targeting the same region, which involves major contributions of both the light and heavy chains. RVFV-379 also uses an oblique angle of approach towards the virion surface that contrasts with the perpendicular angle of engagement observed for some other potently neutralizing human mAbs. Further, consistent with amino acid sequence variation within and proximal to the RVFV-379 epitope, in vitro neutralization screening reveals a limited degree of neutralization breadth across prevalent RVFV strains, suggesting that RVFV has fewer functional constraints at this region of the virus envelope. By dissecting the molecular determinants of mAb recognition of Gn, this integrated analysis refines strategies needed for the rational design of vaccines that can elicit a potent and species-wide protective antibody immune response to this important re-emerging pathogen.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Rift Valley fever virusAntibodies, NeutralizingAntibodies, MonoclonalAntibodies, ViralViral Envelope ProteinsHumansEpitopesRift Valley FeverAnimalsEpitope Mapping

Substanzen

Antibodies, NeutralizingAntibodies, MonoclonalAntibodies, ViralEpitopesViral Envelope Proteins

Autor:innen und Institutionen

  • Division of Structural Biology, Centre for Human Genetics, University of Oxford, Oxford, United Kingdom.
  • Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee, United States of America.
  • Vanderbilt Center for Antibody Therapeutics, Vanderbilt University Medical Center, Nashville, Tennessee, United States of America.
  • Department of Animal, Dairy and Veterinary Sciences, Utah State University, Logan, Utah, United States of America.
  • University of Pittsburgh, Center for Vaccine Research, Pittsburgh, Pennsylvania, United States of America.
  • University of Pittsburgh, Department of Infectious Diseases and Microbiology, School of Public Health, Pittsburgh, Pennsylvania, United States of America.

ORCID-Profile: Thomas A Bowden

Förderung

  • NIAID NIH HHS
  • Medical Research Council
  • NIH
  • Wellcome Trust

Zitieren

APA

Paesen, G. C., Chapman, N. S., Westover, J. B., McMillen, C. M., Kuzmina, N. A., Dews, E. A., Myers, L., Stass, R., Montgomery, J. M., Bukreyev, A., Hartman, A. L., Gowen, B. B., Crowe, J. E., & Bowden, T. A. (2026). Structural basis for recognition of Rift Valley fever virus Gn protein by a human neutralizing monoclonal antibody with a kappa light chain. PLOS Pathogens. https://doi.org/10.1371/journal.ppat.1013926

Vancouver

Paesen GC, Chapman NS, Westover JB, McMillen CM, Kuzmina NA, Dews EA, et al. Structural basis for recognition of Rift Valley fever virus Gn protein by a human neutralizing monoclonal antibody with a kappa light chain. PLOS Pathogens. 2026. doi:10.1371/journal.ppat.1013926

BibTeX
@article{Paesen2026,
  author = {Paesen, Guido C and Chapman, Nathaniel S and Westover, Jonna B and McMillen, Cynthia M and Kuzmina, Natalia A and Dews, Emmett A and Myers, Luke and Stass, Robert and Montgomery, Joel M and Bukreyev, Alexander and Hartman, Amy L and Gowen, Brian B and Crowe, James E and Bowden, Thomas A},
  title = {Structural basis for recognition of Rift Valley fever virus Gn protein by a human neutralizing monoclonal antibody with a kappa light chain},
  journal = {PLOS Pathogens},
  year = {2026},
  doi = {10.1371/journal.ppat.1013926}
}
Kostenlos starten →